Overview
Donepezil is a piperidine-class pharmaceutical compound developed for neurological applications. As the active ingredient in Aricept, it represents a cornerstone in Alzheimer's disease therapy since its 1996 FDA approval. The molecule's design specifically targets central nervous system acetylcholinesterase with minimal peripheral activity. Chemically classified as 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine, donepezil demonstrates remarkable selectivity for brain tissue. Its development marked a significant advancement over earlier cholinesterase inhibitors like tacrine, offering improved safety and dosing profiles.
Physical and Chemical Properties
Donepezil presents as a white to off-white crystalline powder with characteristic physicochemical stability. The compound melts sharply at 211-212°C without decomposition, indicating high purity requirements for pharmaceutical use. Its logP value of 3.1 suggests good blood-brain barrier penetration. Spectroscopic analysis reveals key functional groups: the indanone moiety (UV λmax 271 nm), piperidine nitrogen (pKa 8.9), and dimethoxy aromatic system. The molecule's stereochemistry is crucial - only the (R)-enantiomer shows therapeutic activity, necessitating chiral synthesis or resolution in production.
Main Applications
Donepezil's primary application is the symptomatic treatment of mild to moderate Alzheimer's dementia. By reversibly inhibiting acetylcholinesterase, it elevates synaptic acetylcholine levels, partially compensating for cholinergic neuron degeneration. Clinical studies demonstrate measurable improvements in cognition, global function, and activities of daily living. The pharmaceutical industry also investigates donepezil for other cognitive disorders, including vascular dementia and Lewy body dementia. Off-label uses include enhancement of postoperative cognitive function and management of anticholinergic syndrome. Formulations range from immediate-release tablets to orally disintegrating variants for geriatric patients.
Safety and Storage
Industrial handling requires appropriate PPE including nitrile gloves, safety goggles, and respiratory protection when handling powder forms. The compound shows low acute toxicity (LD50 >2000 mg/kg orally in rats) but may cause cholinergic effects with excessive exposure. Storage demands strict temperature control (2-8°C) in amber glass containers with desiccant packs. Stability studies indicate ≤3% degradation over 24 months when properly stored. Incompatibilities include strong oxidizers and acids - decomposition may release toxic nitrogen oxides under extreme conditions.
B2B Procurement Guide
Pharmaceutical manufacturers should verify suppliers' GMP compliance and analytical methodologies. Key quality parameters include enantiomeric purity (>99.5% (R)-isomer), residual solvent levels (ICH Q3C compliance), and microbial limits. Batch certificates should include HPLC chromatograms and NMR spectra. Bulk procurement typically involves 5-25kg quantities with lead times of 4-8 weeks. Consider dual sourcing strategies due to complex synthesis involving multiple chiral centers. Regulatory documentation packages must include DMF references or equivalent for major markets (US, EU, Japan).
Related Manufacturers
- 主营：单磷酸、白果酸、银杏酸、澳洲茄碱、澳洲茄胺、红四氮唑、白当归脑、曲氟胸苷、安石榴苷、二磷酸葡、白术内酯、四氮唑蓝、巴卡亭iii、白藜芦醇、脱氧尿苷、澳洲茄边、白当归素、脱氧腺苷、腺苷一水合、二磷酸钠盐、白花前胡丙、羟甲香豆素、尿苷三磷酸、菝葜皂苷元、磷酸二钠盐
- 主营：甘氨酸、甘氨酰、硫酸锌、萘苯胺、萘酚绿、二苯胍、羟钴胺、磷酸铵、牛磺酸、褪黑素、肉桂醇、中性红、碳酸镁、肉桂醛、视黄醛、丙炔酸、alliinase、茜素红、肠激酶、达比加、脯氨酸、异丁苯、辛基酚、碘乙烷、叶绿素
- 主营：荧光素酶、血管紧张素转化酶、乳酸氧化酶、乙酰胆碱酯酶、脱氧核糖核酸酶1型、硫酸软骨素ABC酶、肝素酶